keyword
gastrointestin
nematod
lungworm
liver
fluke
vaccin
vaccin
parasit
helminth
livestock
current
market
name
dictyocaulu
viviparu
cattl
haemonchu
contortu
sheep
tapeworm
echinococcu
granulosu
sheep
research
ongo
develop
vaccin
base
purifi
recombinantli
express
worm
protein
ostertagia
ostertagi
cooperia
oncophora
cattl
teladorsagia
circumcincta
h
contortu
sheep
fasciola
hepatica
rumin
recombin
express
worm
antigen
correct
conform
induc
protect
immun
still
major
challeng
vaccin
develop
vaccin
like
part
integr
worm
control
togeth
control
measur
anthelmint
treatment
biolog
control
graze
manag
interdisciplinari
research
includ
social
scienc
investig
driver
farmer
veterinarian
decis
make
optim
uptak
vaccin
end
user
vet
clin
food
anim
major
helminth
infect
rumin
includ
gastrointestin
gi
nematod
liver
fluke
lungworm
present
mainli
control
regular
treatment
anthelmint
drug
howev
decad
intens
use
anthelmint
led
develop
anthelmint
resist
high
level
resist
class
anthelmint
report
gi
nematod
small
rumin
worldwid
resist
macrocycl
lacton
also
emerg
cattl
parasit
mainli
cooperia
spp
lesser
extent
ostertagia
ostertagi
resist
flukicid
report
fasciola
hepatica
sever
countri
togeth
sustain
use
anthelmint
potenti
altern
complementari
control
method
includ
bioactiv
forag
select
breed
host
resist
resili
nematophag
fungi
vaccin
vaccin
consid
favor
option
durabl
protect
provid
lack
chemic
residu
anim
product
environ
principl
vaccin
induc
immunolog
protect
host
subsequ
infect
immun
system
stimul
either
weaken
kill
pathogen
proteinsantigen
socal
subunit
vaccin
fig
subunit
vaccin
base
singl
antigen
mixtur
antigen
purifi
parasit
produc
recombin
dna
technolog
approach
produc
commerci
vaccin
straight
worm
materi
applic
parasit
speci
practic
difficult
even
imposs
obtain
larg
enough
quantiti
parasit
materi
reason
recombin
vaccin
evalu
rang
helminth
howev
maintain
correct
conform
target
antigen
recombin
form
major
challeng
recombin
vaccin
antigen
shown
protect
challeng
develop
lie
deliv
promis
subunit
vaccin
manner
feasibl
largescal
commerci
product
test
efficaci
extens
field
trial
make
fit
purpos
commerci
endus
uptak
despit
strong
effort
develop
antiparasit
vaccin
vaccin
current
market
tabl
providean
hidatil
tecnovax
avail
commerci
market
part
south
america
control
echinococcu
granulosu
sheep
goat
articl
summar
state
art
vaccin
research
sheep
cattl
helminth
includ
lungworm
viviparu
gi
nematod
haemonchu
contortu
teladorsagia
circumcincta
ostertagi
cooperia
oncophora
liver
fluke
f
hepatica
furthermor
safeti
efficaci
requir
implement
helminth
vaccin
field
condit
discuss
well
factor
may
affect
uptak
vaccin
end
user
commerci
lungworm
vaccin
bovili
huskvac
msd
anim
health
compos
live
irradi
thirdstag
viviparu
larva
develop
decad
ago
two
dose
viabl
irradi
larva
deliv
oral
interv
approxim
week
full
vaccin
schedul
complet
least
week
turnout
vaccin
anim
pastur
vaccin
cattl
treat
anthelmint
least
week
second
vaccin
vaccin
use
healthi
cattl
week
age
older
includ
graze
young
stock
adult
cow
although
vaccineinduc
protect
gener
good
vaccin
disadvantag
associ
live
vaccin
ethic
issu
product
larva
donor
anim
batch
heterogen
short
shelf
life
attempt
overcom
issu
sever
attempt
made
develop
recombin
subunit
vaccin
limit
success
vaccin
recombin
acetylcholinesteras
paramyosin
asparaginyl
peptidas
differ
adjuv
result
signific
andor
reproduc
reduct
worm
number
larval
shed
h
contortu
vaccin
base
worm
gut
membran
antigen
mixtur
recent
commerci
sheep
barbervax
wirevax
quickli
becom
invalu
tool
control
haemonchosi
area
anthelmint
resist
rampant
vaccin
regist
australia
south
africa
use
unit
kingdom
special
treatment
certif
veterinari
prescript
vaccin
vaccin
also
confer
protect
haemonchu
placei
graze
calv
vaccin
regist
use
cattl
vaccin
young
goat
suffici
protect
h
contortu
infect
pastur
product
vaccin
nativ
antigen
need
extract
purifi
local
adult
h
contortu
deriv
infect
sheep
vaccin
base
recombinantli
express
antigen
would
advantag
compar
nativ
antigen
vaccin
reproduc
product
batch
biosafeti
global
distribut
mani
effort
made
identifi
express
rang
antigen
h
contortu
recombin
protein
unsuccess
elicit
protect
immun
recent
gene
encod
somat
antigen
identifi
express
escherichia
coli
lamb
vaccin
recombin
antigen
significantli
protect
artifici
challeng
infect
reduct
fecal
egg
count
fec
averag
abomas
parasit
burden
compar
challeng
control
work
promis
step
toward
recombin
haemonchu
vaccin
experi
need
confirm
result
test
vaccin
natur
infect
condit
similar
h
contortu
year
sever
antigen
evalu
vaccin
candid
sheep
abomas
parasit
circumcincta
promis
result
recent
obtain
experiment
vaccin
base
cocktail
recombin
protein
nativ
version
antigen
origin
identifi
either
immunodomin
excretorysecretori
protein
select
potenti
immun
modulatori
role
homologu
vaccin
candid
relat
nematod
speci
protein
express
e
coli
yeast
pichia
pastori
vaccin
antigen
cocktail
quil
adjuv
protect
lamb
periparturi
ewe
challeng
infect
result
significantli
reduc
fec
reduct
lamb
ewe
worm
burden
reduct
lamb
work
ongo
refin
protein
cocktail
test
fewer
recombin
protein
combin
vaccin
trial
protect
capac
test
newli
wean
lamb
field
trial
last
year
sever
antigen
antigen
mixtur
evalu
ostertagi
review
rinaldi
geldhof
present
promis
experiment
vaccin
ostertagi
base
activationassoci
secret
protein
asp
vaccin
fraction
adult
excretorysecretori
product
contain
asp
purifi
protein
consist
result
significantli
reduc
worm
egg
output
reduct
artifici
trickl
challeng
infect
attempt
gener
similar
level
protect
recombin
asp
protein
unsuccess
far
recombin
protein
express
differ
express
system
e
coli
insect
cell
p
pastori
either
insolubl
protect
vaccin
calv
challeng
infect
current
research
focus
elicit
differ
protein
fold
glycosyl
nativ
recombin
asp
protein
identifi
epitop
import
induc
protect
immun
respons
cooperia
oncophora
base
promis
result
obtain
aspbas
vaccin
ostertagi
doubledomain
asp
ddasp
protein
purifi
excretorysecretori
materi
adult
c
oncophora
worm
recent
success
evalu
vaccin
candid
immun
antigen
result
signific
reduct
cumul
fec
experiment
challeng
experi
subsequ
field
trial
c
oncophora
cumul
fec
vaccin
reduc
result
less
infect
c
oncophora
larva
plot
graze
vaccin
calv
signific
reduct
worm
count
vaccin
hous
vaccin
c
oncophora
ddasp
also
protect
calv
challeng
infect
uruguayan
isol
mix
c
oncophora
cooperia
punctata
suggest
protect
epitop
conserv
cooperia
speciesisol
differ
part
world
contrast
c
oncophora
ddasp
vaccin
protect
sheep
cooperia
curticei
unpublish
result
ostertagi
research
current
focus
recombin
express
asp
immuneact
form
overview
individu
antigen
combin
thereof
test
liver
fluke
f
hepatica
fasciola
gigantica
cattl
sheep
given
toet
colleagu
antigen
cathepsin
leucin
aminopeptidas
lap
induc
signific
protect
level
sheep
andor
cattl
nativ
purifi
antigen
recombin
protein
howev
protect
level
highli
variabl
henc
need
test
vaccin
multipl
vaccin
trial
show
consist
protect
combin
differ
antigen
cathepsin
lap
hemoglobin
vaccin
chimer
protein
compos
leucin
aminopeptidas
cathepsin
substanti
improv
vaccin
efficaci
despit
multipl
individu
studi
show
promis
result
variou
dna
vaccin
candid
fascioliasi
anim
model
systemat
review
metaanalysi
show
signific
pool
efficaci
vaccin
candid
fasciola
infect
ideal
parasit
vaccin
safe
high
efficaci
ideal
activ
extent
wide
rang
parasit
safeti
absolut
requir
new
vaccin
avoid
unwant
contamin
protein
pathogen
ensur
batch
reproduc
recombin
protein
dna
vaccin
would
prefer
vaccin
consist
nativ
protein
purifi
worm
collect
anim
vaccin
recombin
protein
cocktail
combin
welldefin
commerci
adjuv
expect
rais
import
safeti
issu
nevertheless
develop
human
hookworm
vaccin
base
asp
caus
allerg
reaction
vaccin
preexpos
individu
sever
vaccin
current
experiment
evalu
livestock
helminth
also
contain
asp
ostertagi
c
oncophora
circumcincta
side
effect
observ
calv
vaccin
doubledomain
asp
c
oncophora
turnout
pastur
test
yet
whether
vaccin
safe
use
region
yearlong
graze
anim
like
infect
vaccin
howev
nisbet
colleagu
observ
advers
reaction
graze
ewe
vaccin
recombin
circumcincta
vaccin
contain
asp
major
aim
control
helminth
infect
vaccin
reduc
parasit
transmiss
decreas
number
viabl
egg
excret
environ
determin
number
infect
larva
pastur
later
graze
season
fecund
ostertagia
highli
regul
host
immun
fecal
egg
output
strongli
reduc
without
reduct
worm
number
contrast
fecund
haemonchu
regul
intens
infect
good
correl
total
daili
fec
matur
femal
worm
burden
consequ
prevent
buildup
high
pastur
infect
level
haemonchu
vaccin
need
reduc
number
adult
worm
present
anim
earli
graze
season
either
reduc
establish
infect
larva
increas
mortal
establish
worm
advantag
vaccin
base
hidden
antigen
see
fig
produc
protect
effect
situat
natur
immun
either
weak
ineffect
young
lamb
periparturi
ewe
disadvantag
vaccineinduc
immun
boost
challeng
infect
hidden
antigen
ingest
worm
expos
host
immun
system
consequ
immun
induc
vaccin
hidden
antigen
typic
short
last
anim
need
revaccin
regularli
need
shown
vaccin
schedul
h
contortu
sheep
lamb
first
receiv
barbervax
dose
vaccin
interv
week
requir
reach
effect
level
antibodi
wherea
subsequ
vaccin
given
week
h
contortu
infect
longer
risk
wwwwormbosscomau
anim
vaccin
convent
antigen
see
fig
benefit
restimul
immun
system
correspond
antigen
challeng
infect
level
durat
protect
requir
depend
local
graze
manag
climat
condit
sheep
lamb
dam
need
vaccin
ewe
contribut
significantli
pastur
infect
periparturi
increas
egg
shed
lamb
vulner
lack
acquir
immun
therefor
experiment
circumcincta
vaccin
test
age
categori
separ
vaccin
schedul
design
lamb
ewe
commerci
h
contortu
vaccin
wwwbarbervaxcomau
dairi
cattl
calv
typic
separ
dam
birth
heifer
calv
rais
separ
group
replac
stock
first
graze
season
calv
suscept
infect
gi
nematod
parasit
gastroenter
mainli
seen
age
class
appropri
prevent
measur
taken
mani
part
europ
welldefin
graze
period
spring
autumn
helminthna
calv
vaccin
turnout
vaccin
protect
natur
immun
suffici
develop
natur
immun
c
oncophora
develop
within
first
month
graze
immun
develop
ostertagi
slow
vaccin
protect
calv
entir
first
graze
season
peak
egg
output
occur
around
month
turnout
anticip
reduct
worm
egg
shed
first
month
turnout
may
suffici
prevent
accumul
infect
larva
pastur
protect
vaccin
anim
hous
autumn
author
previous
suggest
vaccin
reduc
mean
fecal
egg
output
around
first
month
turnout
would
suffici
protect
calv
gi
nematod
first
graze
season
allow
develop
natur
immun
without
product
loss
c
oncophora
shown
achiev
goal
whether
assumpt
hold
ostertagi
field
condit
remain
confirm
moreov
expect
take
account
individu
variabl
calv
respons
vaccin
requir
level
vaccin
efficaci
durat
protect
depend
hostparasit
system
graze
manag
influenc
climat
shortterm
protect
may
suffic
gi
nematod
cattl
region
restrict
graze
season
europ
region
continu
graze
throughout
year
eg
south
america
new
zealand
requir
durat
protect
offer
vaccin
may
similar
parasit
rapidli
induc
natur
immun
cooperia
longer
protect
vaccin
may
need
parasit
slower
immun
develop
ostertagia
fasciola
f
hepatica
infect
level
greater
fluke
cattl
fluke
sheep
associ
product
loss
order
reduc
fluke
burden
threshold
valu
take
account
report
fluke
burden
differ
countri
vaccin
efficaci
fasciola
reach
accord
toet
colleagu
howev
specifi
whether
reduct
fluke
burden
obtain
direct
effect
vaccin
worm
viabil
indirectli
reduc
worm
egg
output
vaccin
anim
estim
indirect
effect
reduc
egg
shed
adult
fluke
burden
complic
role
intermedi
snail
host
parasit
transmiss
snail
infect
singl
miracidium
produc
sever
hundr
cercaria
snail
biolog
signific
impact
outcom
vaccin
region
graze
rumin
coinfect
sever
pathogen
worm
speci
exampl
h
contortu
circumcincta
trichostrongylu
spp
sheep
cattl
ostertagi
cooperia
spp
plu
other
lower
level
multival
vaccin
protect
multipl
gi
nematod
andor
lungworm
liver
fluke
could
obviou
advantag
compar
singlespeci
vaccin
howev
monoval
vaccin
may
use
situat
singl
parasit
speci
domin
eg
h
contortu
warmer
region
parasit
control
altern
measur
region
risk
parasit
low
eg
dri
region
low
risk
liver
fluke
infect
littl
research
multispeci
helminth
vaccin
conduct
knowledg
crossprotect
observ
ostertagi
cattl
vaccin
c
oncophora
ddasp
vaccin
despit
similar
asp
antigen
worm
speci
helminth
vaccin
could
also
combin
vaccin
pathogen
howev
vaccin
multipl
pathogen
particularli
use
tackl
common
diseas
complex
neonat
bovin
diarrhea
combin
vaccin
e
coli
rotaviru
coronaviru
bovin
respiratori
diseas
eg
vaccin
bovin
respiratori
syncyti
viru
parainfluenza
viru
mannheimia
haemolytica
parasit
gastroenter
lungworm
diseas
welldefin
diseas
entiti
graze
rumin
combin
gi
nematod
lungworm
vaccin
bacteri
viral
antigen
may
littl
advantag
mani
case
vaccin
standalon
solut
especi
vaccin
target
singl
parasit
speci
andor
confer
partial
protect
howev
vaccin
even
partial
effect
could
becom
import
compon
integr
worm
control
program
anthelmint
treatment
particular
time
point
vaccin
schedul
barbervax
vaccin
recommend
sheep
cope
concurr
trichostrongylu
infect
earli
haemonchu
infect
wwwbarbervaxcomau
larg
variabl
immun
respons
vaccin
individu
anim
anim
respond
poorli
vaccin
may
need
identifi
either
treat
remov
group
likewis
herd
immun
lead
reduc
level
pastur
contamin
help
protect
anim
respond
poorli
would
imposs
task
test
huge
number
possibl
scenario
aris
combin
multispeci
vaccin
worm
control
measur
differ
manag
system
climat
condit
field
vaccin
trial
contrast
helminth
transmiss
model
use
tool
evalu
differ
scenario
silico
select
promis
combin
control
method
field
test
barn
colleagu
model
popul
dynam
trichostrongylu
colubriformi
sheep
predict
effect
differ
vaccin
worm
popul
dynam
graze
lamb
conclud
vaccin
base
convent
antigen
substanti
benefit
obtain
decreas
larval
establish
flock
simul
refer
sever
articl
argu
essenti
vaccin
gi
nematod
rumin
obtain
efficaci
even
anim
howev
result
readili
extrapol
hostparasit
system
exampl
suppress
egg
product
main
effect
vaccineinduc
immun
rather
decreas
larval
establish
turner
colleagu
develop
mathemat
model
simul
effect
liver
fluke
vaccin
field
condit
model
output
suggest
current
vaccin
candid
potenti
reduc
mean
total
fluke
burden
mean
daili
egg
output
much
field
condit
howev
effect
vaccin
protect
least
anim
whole
graze
season
seem
unlik
level
durat
protect
achiev
vaccin
alon
vaccin
could
contribut
substanti
toward
fasciolosi
control
reduc
usag
anthelmint
thu
delay
spread
anthelmint
resist
unlik
use
helminth
vaccin
impos
polici
maker
helminth
infect
livestock
consid
product
diseas
without
import
public
health
intern
trade
consequ
decis
vaccin
farmer
respons
among
thing
depend
vaccin
perform
costeffect
comparison
altern
control
measur
shown
success
barbervax
vaccin
despit
need
vaccin
sheep
regular
basi
combin
vaccin
anthelmint
treatment
farmer
will
use
vaccin
anthelmint
alon
becom
insuffici
control
haemonchu
infect
region
high
level
anthelmint
resist
contrast
lungworm
vaccin
use
extens
mani
countri
despit
good
vaccin
efficaci
practic
concern
short
shelf
life
avail
anthelmint
persist
efficaci
dictyocaulu
appar
made
vaccin
less
attract
control
option
although
ultim
may
farmer
decis
vaccin
veterinarian
import
role
implement
improv
vaccin
strategi
sociopsycholog
studi
identifi
driver
farmer
veterinarian
decis
make
crucial
optim
uptak
novel
parasit
control
tool
vaccin
express
recombin
vaccin
antigen
right
conform
induc
protect
immun
respons
remain
issu
mani
nematod
vaccin
studi
allel
variabl
target
gene
protein
conform
secondari
modif
antigen
help
steer
recombin
express
work
ultim
lead
develop
protect
recombin
antigen
addit
increas
knowledg
vaccineinduc
immun
respons
lead
optim
antigenadjuv
combin
improv
vaccin
deliveri
sustain
vaccin
like
anthelmint
depend
parasit
evolut
abil
helminth
develop
resist
vaccineinduc
host
respons
remain
open
question
vaccin
contain
multipl
antigen
singl
parasit
speci
could
slow
adapt
parasit
vaccin
experiment
teladorsagia
vaccin
sheep
compris
multipl
recombin
protein
effect
level
durat
vaccin
efficaci
parasit
transmiss
anim
product
combin
use
vaccin
control
method
differ
manag
system
climat
region
simul
use
mathemat
model
inform
vaccin
develop
regulatori
author
possibl
outcom
scenario
parallel
consum
expect
helminth
vaccin
investig
driver
inhibitor
farmer
veterinarian
uptak
parasit
vaccin
identifi
ensur
vaccin
readi
commerci
effect
use
incorpor
routin
farm
manag
diseas
control
articl
base
work
fund
european
union
horizon
research
innov
programm
grant
agreement
paragon
cost
action
combar
support
cost
european
cooper
scienc
technolog
research
vaccin
develop
ostertagi
c
oncophora
describ
articl
financi
support
zoeti
